[The expression of peripheral blood neutrophil CD64 in XXXX with @entity281 or disease activation].

@entity1 @entity1252 @entity1050 @entity281 @entity1851
OBJECTIVE: To explore the significance of expression of peripheral blood neutrophil @entity1050 (64) to distinguish @entity281 from disease activation in @entity1252 ( @entity1252 ). METHODS: 19 @entity1 with @entity281 and 46 @entity1 with @entity281 in 65 @entity1252 @entity1 were studied. The levels of peripheral blood neutrophil @entity1050 (64) were measured by flow cytometry. RESULTS: The levels of peripheral blood neutrophil @entity1050 (64) in @entity1252 @entity1 were [(7.8 +/- 2.1)%], which were significantly higher than that of @entity281 group [(3.2 +/- 1.4)%] and healthy control [(3.0 +/- 1.1)%, P > 0.05]. However, there were no significance between the levels of @entity281 group and healthy control (P > 0.05). There were no significance between the levels of @entity1050 (64) of disease activation and silence group and @entity281 group (P > 0.05). In @entity1252 group, the levels of @entity1050 (64) expression in @entity1 with Gram-negative [(9.2 +/- 1.6)%] were compared with [(7.2 +/- 2.2)%] those with Gram-positive. The differences were not significant (P > 0.05). The levels of @entity1050 (64) of @entity1252 @entity1 with @entity281 were decreased by treatment with antibiotics. The correlation of the levels of @entity1050 (64) with anti-dsDNA, C(3), ESR, @entity1851 , @entity1252 activity index and IFANA were not found (respectively r = 0.104, P = 0.409; r = -0.125, P = 0.322; r = -0.138, P = 0.274; r = 0.228, P = 0.068; r = 0.204, P = 0.310; r = -0.213, P = 0.089). CONCLUSION: The levels of peripheral blood neutrophil @entity1050 (64) may help us distinguish @entity281 from disease activation in @entity1252 .
